PRESTON MYERS: Open Payments
NPI 1205400033 · NEOSHO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 14 payments from 5 companies in 2025. Trend: 2023 $218 · 2024 $251 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $106 |
| ABBVIE INC. | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: Ozempic, QULIPTA, REXULTI, CAPLYTA, Wegovy, VRAYLAR, Rybelsus, LINZESS.
Industry payments across MO — which companies pay providers there.
